Thyroid transcription factor 1 (TTF-1) is thought to play an important role in the expression of genes that encode thyroid-specific proteins such as thyroglobulin, thyroid peroxidase, and TSH receptor. The role of TSH in the regulation of TTF-1 messenger RNA (mRNA) and protein abundance was investigated in rat thyroid FRTL-5 cells. Northern blot analysis revealed that TSH reduced TTF-1 mRNA abundance in a dose-and time-dependent manner. Immunoblot analysis with rabbit antibodies prepared against a recombinant fragment of TTF-1 expressed in bacteria showed that TSH also reduced the amount of TTF-1 protein in FRTL-5 cells. Whereas the effect of TSH on TTF-1 mRNA was apparent after 3 h, the effect on TTF-1 protein was not apparent until 12 h after TSH addition to the cells. Both TTF-1 mRNA and protein were significantly decreased after the addition of (Bu) 2 cAMP or forskolin for 24 h, whereas they were not decreased by 12-O-tetradecanoyl-phorbol-13-acetate. These results indicate that TSH down-regulates TTF-1 expression in FRTL-5 cells via the cAMP pathway. (Endocrinology 138: [602][603][604][605][606] 1997) 
H OMEODOMAIN-CONTAINING proteins, which
contribute to the regulation of morphogenesis in Drosophila, bind to specific DNA sequences and exert their effects through modulation of transcription (1, 2) . Thyroid transcription factor 1 (TTF-1), a homeodomain-containing thyroid-specific transcription factor (3) that is related to the Drosophila NK2 family of homeobox-containing proteins (4) , is thought to be important for thyroid development and differentiation (5) . Thus, TTF-1 is required for the expression of various thyroid-specific genes, including those encoding thyroglobulin (Tg), thyroid peroxidase (TPO), and the TSH receptor (TSHR) (6 -9) . TTF-1 binds to 5Ј flanking region of TSHR gene and stimulates the transcriptional activity, whereas TSH reduces the abundance of TTF-1 messenger RNA (mRNA). Therefore, the downregulation of TTF-1 by TSH seems to contribute to the negative regulation of TSHR in the thyroid (9) . TSH activates both the cAMP and phosphatidylinositol cascades in thyroid cells (10) . Both or either of these two regulatory cascades could be involved in TTF-1 gene activation and protein expression. However, TSH has not been shown directly to reduce the amount of TTF-1 protein in thyroid cells, although the signal corresponding to the TTF-1-DNA complex in a gel mobility shift assay was decreased after treatment of cells with forskolin (9) .
We now have produced rabbit antibodies to TTF-1 with a portion of TTF-1 protein expressed in bacteria as antigen and, with the use of immunoblot analysis with these antibodies, have investigated the effect of TSH on TTF-1 protein expression in rat thyroid FRTL-5 cells.
Materials and Methods

Cell culture
Rat thyroid FRTL-5 cells were cultured in 10-cm dishes containing Coon's modified Ham's F12 medium supplemented with 5% calf serum (GIBCO, Grand Island, NY) and a 6-hormone mixture containing bovine TSH (5 mU/ml), insulin (10 g/ml), 10 nm hydrocortisone, transferrin (5 g/ml), SRIF (10 ng/ml), and glycyl-L-histidyl-L-lysine acetate (10 ng/ml) as described previously (11, 12) . After achieving 70 -80% confluence, the cells were maintained in the same medium without TSH and cultured for an additional 5 days. Cells then were subjected to the experiments. BRL-3A rat liver cells were cultured in 10-cm dishes containing Coon's modified Ham's F12 medium supplemented with 5% FBS without the 6 hormones.
Northern blot analysis
Total RNA was isolated from cells with acidic guanidine isothiocyanate-phenol-chloroform extraction (13) , fractionated (15 g per lane) by electrophoresis through 1% agarose gels, and transferred to nylon filters (Zeta Probe, Bio-Rad, Richmond, CA). The filters were hybridized with a 32 P-labeled probe corresponding to nucleotides ϩ1 to ϩ331 (relative to the translation start site) of TTF-1 complementary DNA (cDNA) or rat ␤-actin cDNA and then washed as previously described (12) . Signals corresponding to TTF-1 mRNA were quantitated with a BAS 2000 system (Fujix, Tokyo, Japan).
Preparation of TTF-1 antibodies
A recombinant partial TTF-1 residue, corresponding to 1 to 126, expressed in bacteria with pGEX-2T (Pharmacia Biotech, Uppsala, Sweden) was purified using Glutathione Sepharose 4B (Pharmacia). Antisera were raised in rabbits by serial injections of emulsion of the protein (1 mg/ml) in Freunt's complete adjuvant (Wako, Osaka, Japan), and after 10 weeks, the sera were used in the experiments.
Gel mobility shift assay
Nuclear extracts from FRTL-5 and BRL-3A cells were prepared as described previously (14, 15) . A synthetic double-stranded oligonucleotide probe spanning nucleotides Ϫ194 to Ϫ169 of the TSHR gene promoter, which contains the TTF-1-binding site, was labeled with [␥-32 P]ATP (9) . Nuclear extracts (1.5 g protein) were incubated for 20 min at room temperature in a reaction vol of 20 l containing 10 mm Tris HCl (pH 7.6), 50 mm KCl, 1 mm EDTA, 5 mm MgCl 2 , 12.5% (vol/vol) glycerol, 1 mm dithiothreitol, 0.1% Nonidet P-40, and 1 g poly(dI-dC), either in the absence or presence of rabbit antiserum (1:200 dilution) to recombinant TTF-1 residues 1 to 126 or preimmune serum (1:200 dilution). Labeled probe (6000 cpm, 0.5 ng), with or without unlabeled competitor oligonucleotide (25 or 100 ng), was then added to the reaction mixture, and the incubation was continued for an additional 20 min. DNA-protein complexes were separated on 8% native polyacrylamide gels (9) .
Immunoblot analysis
Nuclear extracts (15 g protein per lane) from FRTL-5, BRL-3A, or COS-7 cells that had been transfected with the pRc/CMV vector containing the full coding sequence of rat TTF-1 cDNA (kindly provided by Dr. R. Di Lauro) were mixed with lysis buffer [62.5 mm Tris-HCl (pH 6.8), 9.5 m urea, 2.3% SDS, 10% glycerol, and 5% ␤-mercaptoethanol], subjected to electrophoresis on 15% polyacrylamide gels containing 0.1% SDS, and transferred to a nitrocellulose membrane. The membrane was then incubated sequentially with rabbit antiserum to TTF-1, peroxidaseconjugated goat antibodies to rabbit IgG, and diaminobenzidine (Dojindo, Kumamoto, Japan) as previously described (12) . The protein abundance was quantitated by scanning densitometer (GT-8000, EPSON, Tokyo, Japan).
Results
Northern blot analysis of TTF-1 mRNA
First, we determined TTF-1 mRNA signal in FRTL-5 cells, and the strong signal was seen in the position of approximately 2.7 kb as reported in the previous study (3) . To investigate the effect of TSH on the TTF-1 mRNA amount, the following experiments were performed. Northern blot analysis revealed abundant TTF-1 mRNA in untreated FRTL-5 cells and that incubation of cells with TSH (5 mU/ml) for 3 or 24 h reduced the amount of this mRNA (Fig. 1A) . TTF-1 mRNA was not detected in BRL-3A cells. The TSH-induced decrease in the amount of TTF-1 mRNA in FRTL-5 cells was dose dependent for concentration of Ͼ 1 mU/ml (Fig. 1B) . Figure 2 shows time-dependent TSH effect on the amount of TTF-1 mRNA in FRTL-5 cells. It was reduced by 50 and 66% after incubation with TSH (5 mU/ml) for 3 and 24 h, respectively; exposure to TSH for 1 h did not affect transcript abundance. TTF-1 mRNA amount was reduced rapidly during a few hours.
Production and characterization of antiserum to TTF-1
We produced a rabbit antiserum to TTF-1 by immunization with a recombinant fragment of TTF-1 expressed in bacteria. To confirm the specificity of the antiserum, a gel mobility shift analysis was performed using a TTF-1-binding site located in the 5Ј flanking region of the TSHR gene. Figure  3A shows the gel mobility shift analysis with nuclear extract from FRTL-5 cells, in which TTF-1 migrated in the position of the lower arrow; competing unlabeled oligonucleotide reduced the radioactivity at this position in a dose-dependent manner (lanes a to c). Antiserum to TTF-1 induced a shift in the position of the labeled band to that indicated by the upper arrow, whereas preimmune serum did not, suggesting the specific binding of the antiserum to TTF-1 protein. Nuclear extract from BRL-3A cells did not yield a TTF-1 band. The band below TTF-1 from FRTL-5 cells seems to correspond to a single-stranded DNA-binding protein described previously (9, 13).
We also confirmed the specificity of the antiserum to TTF-1 by immunoblot analysis. The antiserum detected TTF-1 (46 kDa) in the nuclear extract of COS-7 cells transfected with TTF-1 cDNA in the pRc/CMV vector but not in the nuclear extract of BRL-3A cells (Fig. 3B) . Preimmune serum did not detect TTF-1 in the nuclear extract of the transfected cells.
Effect of TSH on TTF-1 protein
To further elucidate the down-regulation of TTF-1 by TSH, nuclear extracts prepared from FRTL-5 cells that had been incubated with TSH for various times were subjected to immunoblot analysis with the antiserum to TTF-1. A decrease in the amount of TTF-1 protein (46 kDa) was first detected after incubation of cells with TSH for 12 h and was still apparent after 24 h (Fig. 4A) . In contrast, Northern blot analysis of total RNA from the same batch of cells showed that TTF-1 mRNA abundance was decreased after incubation of cells with TSH for 3 h (Fig. 4B) .
Effect of (Bu) 2 cAMP, forskolin, and 12-O-tetradecanoylphorbol-13-acetate (TPA)
To clarify a possible mechanism of action of TSH in the regulation of TTF-1 expression, (Bu) 2 cAMP, forskolin, or TPA was added to the cells, and the levels of TTF-1 mRNA and protein were determined. Figure 5 shows that both TTF-1 mRNA and protein were significantly decreased after the addition of (Bu) 2 cAMP (1 mm) or forskolin (10 m) for 24 h, whereas TPA (200 nm) had no effect on the abundance of the mRNA and protein.
Discussion
The rat TTF-1 cDNA encodes a 378-amino acid protein with a calculated molecular mass of 38 kDa (3). Purified TTF-1 from HeLa spinner cells infected with a vaccinia virus containing the entire TTF-1 open reading frame was previously shown to migrate on SDS-PAGE with an apparent molecular mass of 38 kDa (16) . We now have shown that antibodies prepared against residues 1-126 of TTF-1 detect a portion of 46 kDa. This discrepancy in molecular size might be attributable to posttranslational modification such as phosphorylation, glycosylation, or proteolysis. Van Renterghem et al. (17) reported that the molecular size of TTF-1 was approximately 43-46 kDa in immunoprecipitation and immunoblotting with anti-TTF-1 antibody. This is compatible with our results. Indeed, TTF-1 possesses several phosphorylation sites that might be important determinants of DNA-binding activity (9) and also possesses several glycosylation sites. There were two faint bands just above and beneath the 46-kDa TTF-1 protein in our immunoblot analysis. The possibility that these immunodetected signals might be phosphrylated or dephosphorylated forms of TTF-1 protein can not be disregarded. Although TTF-1 can exist as a dimer as a result of disulfide bond formation between two cysteine residues located outside the homeodomain (16), we performed electrophoresis under reducing conditions.
Our observation of TSH-induced down-regulation of TTF-1 mRNA is consistent with the results of a previous study (9) . We now have demonstrated also that TSH reduces the amount of TTF-1 protein in FRTL-5 cells (Fig. 4) ; this effect was first apparent after 12 h, whereas mRNA downregulation was detected after incubation of cells with TSH for 3 h. Recently, Zannini et al. (18) showed that the amount of 35 S-labeled TTF-1 decreased by 50% in about 14 h in FRTL-5 cells and transfected HeLa cells, suggesting the slow turnover of this protein and also supporting our result. Van Renterghem et al. (17) showed that TTF-1 mRNA abundance was not affected by incubation of primary cultures of dog thyroid with forskolin for 3 days. This apparent discrepancy with our data may be attributed to the difference in primary vs. continuous cell line, FRTL-5. However, it is also possible that species-specific differences exist in TTF-1 gene regulation.
A similar discrepancy in mRNA regulation is apparent also with another thyroid-specific gene, that for TSHR. Saji et al. (19) showed that TSHR mRNA was down-regulated by the TSH-cAMP pathway in FRTL-5 cells, whereas others (20, 21) demonstrated TSH-induced up-regulation of TSHR mRNA in primary cultures of human and dog thyroid cells. 's t test) . B, Effect of TSH on TTF-1 protein and mRNA. FRTL-5 cells were maintained in the absence of TSH for 5 days and then incubated with TSH (5 mU/ml) for 0, 3, 6, 12, 24 h (lanes a-e). Nuclear extracts were prepared and subjected to immunoblot analysis with antiserum to TTF-1. Total RNA was prepared from the cells and subjected to Northern analysis with a TTF-1 cDNA or a rat ␤-actin cDNA probe. Data represent typical experiments that were repeated four times with different batches of cells on different days. . Total RNA and nuclear extract were prepared and subjected to Northern and immunoblot analyses, respectively. The representative data are shown. B, Effect of (Bu) 2 cAMP, forskolin, and TPA on TTF-1 mRNA and protein. Samples were prepared as described in (A). Data are means Ϯ SE of three (Northern analysis) or four (immunoblot analysis) separate experiments with different batches of cells on different days and are expressed relative to none (a). *, P Ͻ 0.005; **, P Ͻ 0.05 vs. none and TPA (Student's t test).
As a cAMP response element (CRE)-like region and a TTF-1-binding site in the 5Ј flanking region of the TSHR gene contribute to the regulation of transcription of this gene (8, 9) , this difference in the regulation of TSHR gene by TSH may reflect that of the TTF-1 gene by TSH.
The regulation of the expression of Tg, TPO, and TSHR genes has been elucidated by analysis of their 5Ј flanking sequences (6 -9, 22, 23) . It was demonstrated that the cAMP pathway had an important role in the down-regulation of TTF-1 mRNA and protein by TSH (Fig. 5) . Although there is unexpectedly no CRE (CREB/CREM consensus sequence) within 2.5 kb of the 5Ј-upstream region of TTF-1 gene (Ref. 24 and unpublished observations), a candidate for the consensus sequence of cAMP receptor protein is located there (25, 26) . Our recent characterization of the 5Ј-flanking region of TTF-1 gene may therefore help to elucidate the mechanism of not only TTF-1 gene regulation by TSH, but also Tg, TPO, and TSHR gene regulation (24) .
